PLANTATION, Fla.--(BUSINESS WIRE)--Oncology Analytics, Inc., today announced that its MATIS™ clinical decision support software has launched, and is actively in use with healthcare plans and providers throughout the U.S. and Puerto Rico. MATIS™ is designed to enhance Oncology Analytics’ evidence-based approach to the evaluation of cancer treatment and benefits management. MATIS™ advantages include improving efficiencies and processing times to deliver timely and accurate responses to provider requests and to provide information on value-based treatment alternatives consistent with the highest standards of oncology care. To keep pace with the company’s growth, its existing, award-winning software application was upgraded using a stronger scalable core for best-in-class turnaround times with improved dashboards for provider usability.
The ability for MATIS™ to give providers choices for their patients allows them to deliver the best oncology treatment with greater confidence at lower costs to the patient and health plan. Additionally, MATIS™ enables providers to automatically confirm eligibility information at the time of authorization, populating all relevant fields with the most current information.
“The mission of Oncology Analytics is to assure that patients receive high quality cost effective cancer care while minimizing administrative burdens for providers," said Marc Fishman, M.D., CEO and Founder of Oncology Analytics, Inc. “MATIS™ software helps us to achieve these goals while enhancing Oncology Analytics’ analytic capabilities.”
For more information on MATIS™ software, or how Oncology Analytics can partner with your health plan to improve patient treatment choices while reducing costs and maintaining provider satisfaction, please contact Marisela Medrano at Oncology Analytics at 954-637-0787.
About Oncology Analytics, Inc.
Founded in Plantation, Florida in 2009, Oncology Analytics, Inc., accredited by URAC for Health Utilization Management, is a comprehensive oncology benefits management company serving health plans, providers, and patients in the U.S. market and Puerto Rico. Oncology Analytics has continued its mission of using evidence-based medicine to drive better treatment options for cancer care at reduced costs. Using a patient focused approach, Oncology Analytics’ clinical team of board certified medical oncologists, oncology RNs, and board certified oncology pharmacists personally review individual cases that require additional assessment for individualized care. Evidence Based. Results Driven. Patient Focused.
